dihydroxyphenylalanine has been researched along with Syndrome in 39 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Syndrome: A characteristic symptom complex.
Excerpt | Relevance | Reference |
---|---|---|
"Unaffected, mutation-positive relatives of index patients with hereditary paraganglioma syndromes were offered PET imaging with [(18)F]fluorodihydroxyphenylalanine and the incidence of pathological findings was retrospectively analysed in relation to mutations of the succinate dehydrogenase enzyme complex." | 7.79 | High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PET. ( Bartsch, O; Fottner, C; Helisch, A; Lackner, KJ; Mann, WJ; Miederer, M; Musholt, TJ; Papaspyrou, K; Rossmann, H; Schreckenberger, M; Weber, MM, 2013) |
"Unaffected, mutation-positive relatives of index patients with hereditary paraganglioma syndromes were offered PET imaging with [(18)F]fluorodihydroxyphenylalanine and the incidence of pathological findings was retrospectively analysed in relation to mutations of the succinate dehydrogenase enzyme complex." | 3.79 | High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PET. ( Bartsch, O; Fottner, C; Helisch, A; Lackner, KJ; Mann, WJ; Miederer, M; Musholt, TJ; Papaspyrou, K; Rossmann, H; Schreckenberger, M; Weber, MM, 2013) |
"We estimated regional and global metabolic rates for glucose using 18F-fluorodeoxyglucose (FDG) and PET in six patients with hemiparkinsonism-hemiatrophy syndrome (HPHA; mean age, 41." | 3.69 | Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome. ( Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Ishikawa, T; Przedborski, S; Spetsieris, P; Takikawa, S, 1994) |
"Transient exposure to the toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces a syndrome resembling idiopathic parkinsonism (IP)." | 3.69 | Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. ( Calne, DB; Langston, JW; Schulzer, M; Snow, BJ; Tetrud, JW; Vingerhoets, FJ, 1994) |
"The Segawa syndrome is an autosomal dominant form of guanosine triphosphate cyclohydrolase deficiency, resulting in decreased dopamine and serotonin levels, typically presenting as a dopa-responsive dystonia." | 1.35 | Uneventful electroconvulsive therapy in a patient with dopa-responsive dystonia (Segawa syndrome). ( Peuskens, J; Rooseleer, J; Sienaert, P, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (69.23) | 18.7374 |
1990's | 5 (12.82) | 18.2507 |
2000's | 3 (7.69) | 29.6817 |
2010's | 3 (7.69) | 24.3611 |
2020's | 1 (2.56) | 2.80 |
Authors | Studies |
---|---|
Béreau, M | 1 |
Van Waes, V | 1 |
Servant, M | 1 |
Magnin, E | 1 |
Tatu, L | 1 |
Anheim, M | 1 |
Sienaert, P | 1 |
Rooseleer, J | 1 |
Peuskens, J | 1 |
Levine, DS | 1 |
Metzger, DL | 1 |
Nadel, HR | 1 |
Oviedo, A | 1 |
Adam, MJ | 1 |
Skarsgard, E | 1 |
Dill, P | 1 |
Schneider, J | 1 |
Weber, P | 1 |
Trachsel, D | 1 |
Tekin, M | 1 |
Jakobs, C | 1 |
Thöny, B | 1 |
Blau, N | 1 |
Miederer, M | 1 |
Fottner, C | 1 |
Rossmann, H | 1 |
Helisch, A | 1 |
Papaspyrou, K | 1 |
Bartsch, O | 1 |
Mann, WJ | 1 |
Musholt, TJ | 1 |
Weber, MM | 1 |
Lackner, KJ | 1 |
Schreckenberger, M | 1 |
Goldstein, DS | 1 |
Holmes, C | 1 |
Frank, SM | 1 |
Dendi, R | 1 |
Cannon, RO | 1 |
Sharabi, Y | 1 |
Esler, MD | 1 |
Eisenhofer, G | 1 |
Brink, I | 1 |
Schaefer, O | 1 |
Walz, M | 1 |
Neumann, HP | 1 |
Krupenina, LB | 1 |
Vinogradov, MV | 1 |
Badalian, LO | 1 |
Temin, PA | 1 |
Dzhabarov, BD | 1 |
Bespalova, VA | 1 |
Kret, LA | 1 |
Magalov, ShI | 1 |
Dadali, EL | 1 |
Arushanian, EB | 1 |
Dutov, AA | 1 |
Anokhina, IP | 1 |
Kogan, BM | 1 |
Przedborski, S | 1 |
Giladi, N | 1 |
Takikawa, S | 1 |
Ishikawa, T | 1 |
Dhawan, V | 1 |
Spetsieris, P | 1 |
Chaly, T | 1 |
Fahn, S | 1 |
Eidelberg, D | 1 |
Vingerhoets, FJ | 1 |
Snow, BJ | 1 |
Tetrud, JW | 1 |
Langston, JW | 1 |
Schulzer, M | 1 |
Calne, DB | 1 |
Turjanski, N | 1 |
Lees, AJ | 1 |
Brooks, DJ | 2 |
Popkova, EV | 1 |
Krupina, NA | 1 |
Kryzhanovskiĭ, GN | 1 |
Orlova, IN | 1 |
Iordanskaia, TE | 1 |
Mishima, Y | 1 |
Barkatova, VP | 1 |
Strelkova, NI | 1 |
Shchepina, TP | 1 |
Lupandin, VM | 1 |
Lando, LI | 1 |
Gromova, EA | 1 |
Kamenskaia, VM | 1 |
Zykov, MB | 1 |
Mosunova, TG | 1 |
Sawle, GV | 1 |
Marsden, CD | 1 |
Frackowiak, RS | 1 |
Patton, MA | 1 |
Baraitser, M | 1 |
Heagerty, AH | 1 |
Eady, RA | 1 |
Piasetskaia, MV | 1 |
Bragina, NN | 1 |
Il'icheva, RF | 1 |
Potapov, AA | 1 |
Leonardi, G | 1 |
Soyka, D | 1 |
Jaffe, RB | 1 |
Yuen, BH | 1 |
Keye, WR | 1 |
Midgley, AR | 1 |
Lance, JW | 1 |
Andrews, C | 1 |
Donaldson, IM | 1 |
Zárate, A | 2 |
Jacobs, LS | 1 |
Canales, ES | 2 |
Schally, AV | 1 |
De la Cruz, A | 1 |
Soria, J | 2 |
Daughaday, WH | 1 |
Varga, L | 1 |
Wenner, R | 1 |
Del Pozo, E | 1 |
Schneider, KW | 1 |
Vaisrub, S | 1 |
Mastaglia, FL | 1 |
Grainger, K | 1 |
Kee, F | 1 |
Sadka, M | 1 |
Lefroy, R | 1 |
Lhermitte, F | 1 |
Chain, F | 1 |
Escourolle, R | 1 |
Chedru, F | 1 |
Guilleminault, C | 1 |
Francoual, M | 1 |
Maneiro, PJ | 1 |
MacGregor, C | 1 |
Strauss, RG | 1 |
Sharpe, J | 1 |
Marquez-Julio, A | 1 |
Ashby, P | 1 |
Edmonds, M | 1 |
Friesen, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Clinical Laboratory Evaluation of Chronic Orthostatic Intolerance[NCT00069693] | 200 participants | Observational | 2003-09-26 | Completed | |||
Propranolol for Syncope With Sympathoadrenal Imbalance[NCT00060866] | Phase 4 | 24 participants | Interventional | 2003-05-31 | Completed | ||
Propranolol for Syncope With Sympathoadrenal Imbalance in Children[NCT00093860] | Phase 2 | 50 participants | Interventional | 2004-10-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for dihydroxyphenylalanine and Syndrome
Article | Year |
---|---|
Apathy in Parkinson's Disease: Clinical Patterns and Neurobiological Basis.
Topics: Apathy; Depression; Dihydroxyphenylalanine; Humans; Limbic System; Parkinson Disease; Syndrome | 2023 |
[Nigrostriatal system as a source of torsion extrapyramidal disorders (review)].
Topics: 5-Hydroxytryptophan; Acetylcholine; Animals; Basal Ganglia Diseases; Cats; Caudate Nucleus; Corpus S | 1980 |
1 trial available for dihydroxyphenylalanine and Syndrome
Article | Year |
---|---|
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; | 2002 |
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; | 2002 |
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; | 2002 |
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; | 2002 |
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; | 2002 |
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; | 2002 |
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; | 2002 |
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; | 2002 |
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; | 2002 |
36 other studies available for dihydroxyphenylalanine and Syndrome
Article | Year |
---|---|
Uneventful electroconvulsive therapy in a patient with dopa-responsive dystonia (Segawa syndrome).
Topics: Affective Disorders, Psychotic; Delusions; Dihydroxyphenylalanine; Dopamine Agents; Dystonia; Electr | 2009 |
Novel use of F-DOPA PET/CT imaging in a child with paraganglioma/pheochromocytoma syndrome.
Topics: Adolescent; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Female; Humans; Kidney Neoplasms; Multi | 2011 |
Pyridoxal phosphate-responsive seizures in a patient with cerebral folate deficiency (CFD) and congenital deafness with labyrinthine aplasia, microtia and microdontia (LAMM).
Topics: Base Sequence; Child; Codon, Nonsense; Congenital Abnormalities; Congenital Microtia; Dihydroxypheny | 2011 |
High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PET.
Topics: Adolescent; Adult; Child; Dihydroxyphenylalanine; False Negative Reactions; Female; Germ-Line Mutati | 2013 |
Fluorine-18 DOPA PET imaging of paraganglioma syndrome.
Topics: Abdominal Neoplasms; Child; Dihydroxyphenylalanine; Head and Neck Neoplasms; Humans; Male; Paragangl | 2006 |
[State of the adrenergic and cholinergic systems of schizophrenic patients during the process of psychopharmacotherapy].
Topics: Acetylcholine; Acetylcholinesterase; Adult; Antipsychotic Agents; Catecholamines; Dihydroxyphenylala | 1980 |
[Catecholamine concentration in the blood and excretion in the urine in different forms of progressive muscular dystrophy].
Topics: Adolescent; Adult; Catecholamines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Humans; Middle Age | 1984 |
[Catecholamine metabolism in Huntington's chorea (in patients and their phenotypically healthy relatives)].
Topics: Adolescent; Adult; Aged; Catecholamines; Child; Dihydroxyphenylalanine; Dopamine; Epinephrine; Femal | 1980 |
[Various features of dopamine metabolism in schizophrenia].
Topics: Dihydroxyphenylalanine; Dopamine; Epinephrine; Homovanillic Acid; Humans; Norepinephrine; Schizophre | 1981 |
Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
Topics: Adult; Atrophy; Brain; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose | 1994 |
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Aged; Aged, 80 and over; Corpus Striatum; Dihyd | 1994 |
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
Topics: Aged; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Kinet | 1999 |
[Monoamine level in the rat brain with MPTP-induced depressive syndrome].
Topics: Animals; Biogenic Monoamines; Brain; Depressive Disorder; Dihydroxyphenylalanine; Dopamine; Dopamine | 1999 |
Histopathology of functional pigmentary disorders.
Topics: Albinism; Animals; Cricetinae; Dihydroxyphenylalanine; Female; Humans; Infant; Melanocytes; Melanosi | 1978 |
[Catecholamine excretion in torsion dystonia].
Topics: Adolescent; Adult; Aged; Catecholamines; Child; Dihydroxyphenylalanine; Dopamine; Dystonia Musculoru | 1978 |
[Humeroscapular periarthritis in patients with cervical osteochondrosis].
Topics: Autonomic Nervous System; Brachial Plexus Neuritis; Cervical Vertebrae; Contracture; Dihydroxyphenyl | 1978 |
[Role of biogenic amines in the pathogenesis of intellectual disorders in children with minimal psychoorganic syndromes].
Topics: Attention Deficit Disorder with Hyperactivity; Catecholamines; Child; Dihydroxyphenylalanine; Electr | 1978 |
[Catecholamines metabolism in extrapyramidal disorders in children].
Topics: Adolescent; Ataxia Telangiectasia; Basal Ganglia Diseases; Catecholamines; Child; Child, Preschool; | 1977 |
Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography.
Topics: Aged; Animals; Apraxias; Brain Diseases; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; E | 1991 |
An oculocerebral hypopigmentation syndrome: a case report with clinical, histochemical, and ultrastructural findings.
Topics: Cerebellar Ataxia; Child, Preschool; Dihydroxyphenylalanine; Humans; Intellectual Disability; Male; | 1987 |
[Use of L-DOPA in the complex treatment of severe craniocerebral injuries].
Topics: Adolescent; Adult; Brain Injuries; Child; Combined Modality Therapy; Dihydroxyphenylalanine; Dopamin | 1987 |
Letter: Acetylcholine poisoning and sympathetic overactivity in tetanus.
Topics: Acetylcholine; Cholinesterase Inhibitors; Curare; Dihydroxyphenylalanine; Humans; Sympathetic Nervou | 1974 |
[Syndrome involving the extrapyramidal motor systems and their drug treatment].
Topics: Amantadine; Antiparkinson Agents; Basal Ganglia Diseases; Dihydroxyphenylalanine; gamma-Aminobutyric | 1974 |
Physiologic and pathologic profiles of circulating human prolactin.
Topics: Adenoma, Chromophobe; Adult; Amenorrhea; Chorionic Gonadotropin; Dihydroxyphenylalanine; Ethinyl Est | 1973 |
Dysaesthesia-dyskinesia: a syndrome of painful legs and moving toes.
Topics: Aged; Amantadine; Amitriptyline; Chlorpromazine; Dihydroxyphenylalanine; Female; Humans; Leg; Moveme | 1973 |
The treatment of progressive supranuclear palsy with L-dopa.
Topics: Aged; Bulbar Palsy, Progressive; Demyelinating Diseases; Dihydroxyphenylalanine; Female; Humans; Mid | 1973 |
Functional evaluation of pituitary reserve in patients with the amenorrhea-galactorrhea syndrome utilizing luteinizing hormone-releasing hormone (LH-RH), L-dopa and chlorpromazine.
Topics: Adult; Amenorrhea; Chlorpromazine; Dihydroxyphenylalanine; Female; Follicle Stimulating Hormone; Gon | 1973 |
Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility.
Topics: Adult; Amenorrhea; Bromine; Clomiphene; Dihydroxyphenylalanine; Ergot Alkaloids; Estrogens; Female; | 1973 |
[Etiology and therapy of the parotid gland syndrome].
Topics: Antihypertensive Agents; Chewing Gum; Clonidine; Dihydroxyphenylalanine; Eating; Humans; Neostigmine | 1973 |
Dementia dialytica.
Topics: Autopsy; Brain; Brain Chemistry; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Electroenceph | 1973 |
Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrome) clinical and electrophysiological observations in eleven cases.
Topics: Aged; Basal Ganglia Diseases; Bulbar Palsy, Progressive; Demyelinating Diseases; Dihydroxyphenylalan | 1973 |
[A further case of tetanus-like contracture distinct from the stiff man syndrome. Pharmacological and neuropathological study of a case of predominantly spinal encephalomyelitis].
Topics: Aged; Carbamazepine; Contracture; Diazepam; Dihydroxyphenylalanine; Electromyography; Encephalomyeli | 1973 |
Effect of acute administration of L-dopa on serum concentrations of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in patients with the amenorrhea-galactorrhea syndrome.
Topics: Administration, Oral; Adult; Amenorrhea; Dihydroxyphenylalanine; Female; Follicle Stimulating Hormon | 1973 |
Failure of methyldopa therapy in Bartter's syndrome.
Topics: Child; Depression, Chemical; Dihydroxyphenylalanine; Humans; Hyperaldosteronism; Hypokalemia; Juxtag | 1974 |
Idiopathic orthostatic hypotension treated with levodopa and MAO inhibitor: a preliminary report.
Topics: Basal Ganglia Diseases; Brain Stem; Catecholamines; Dihydroxyphenylalanine; Drug Synergism; Fecal In | 1972 |
The effect of levodopa on galactorrhea in the Forbes-Albright syndrome.
Topics: Adenoma, Chromophobe; Adult; Dihydroxyphenylalanine; Female; Growth Hormone; Humans; Hysterectomy; L | 1972 |